Short-term metabolic effects of pamidronate in patients with prostatic carcinoma and bone metastases.
Pelger
R C
RC
Lycklama à Nijeholt
A A
AA
Papapoulos
S E
SE
D001859:Bone Neoplasms / Q000378:metabolism* / Q000556:secondary; D001862:Bone Resorption / Q000378:metabolism; D001842:Bone and Bones / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000077268:Pamidronate; D011471:Prostatic Neoplasms; D013997:Time Factors
D004164:Diphosphonates; D000077268:Pamidronate; D002118:Calcium